NCT02553304View on ClinicalTrials.gov

Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients

CompletedOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2021

Conditions
Chronic Lymphocytic Leukemia (CLL)
All Listed Sponsors
lead

National Health Research Institutes, Taiwan

OTHER

NCT02553304 - Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients | Biotech Hunter | Biotech Hunter